These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 27120091)

  • 1. Advances in Pretransplant Donor-Specific Antibody Testing in Solid Organ Transplantation: From Bench to Bedside.
    Focosi D
    Int Rev Immunol; 2016 Jul; 35(4):351-368. PubMed ID: 27120091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA match, mismatch and crossmatch: what clinicians should know?
    Ghosh B; Pahari DK
    J Indian Med Assoc; 2013 Aug; 111(8):524-8. PubMed ID: 24783390
    [No Abstract]   [Full Text] [Related]  

  • 3. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Influence of Immunosuppressive Agents on the Risk of De Novo Donor-Specific HLA Antibody Production in Solid Organ Transplant Recipients.
    OʼLeary JG; Samaniego M; Barrio MC; Potena L; Zeevi A; Djamali A; Cozzi E
    Transplantation; 2016 Jan; 100(1):39-53. PubMed ID: 26680372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Center-defined unacceptable HLA antigens facilitate transplants for sensitized patients in a multi-center kidney exchange program.
    Baxter-Lowe LA; Cecka M; Kamoun M; Sinacore J; Melcher ML
    Am J Transplant; 2014 Jul; 14(7):1592-8. PubMed ID: 24934640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Introduction: What we know about antibodies produced by transplant recipients against donor antigens not encoded by HLA genes.
    Stastny P
    Hum Immunol; 2013 Nov; 74(11):1421-4. PubMed ID: 23770305
    [No Abstract]   [Full Text] [Related]  

  • 7. The impact of pretransplant donor-specific antibodies on graft outcome in renal transplantation: a six-year follow-up study.
    David-Neto E; Souza PS; Panajotopoulos N; Rodrigues H; Ventura CG; David DS; Lemos FB; Agena F; Nahas WC; Kalil JE; Castro MC
    Clinics (Sao Paulo); 2012; 67(4):355-61. PubMed ID: 22522761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of donor-specific antibodies (DSA) and incidence of de novo DSA in solid organ transplant recipients after switch to everolimus alone or associated with low dose of calcineurin inhibitors.
    Perbos E; Juinier E; Guidicelli G; Dromer C; Merville P; Billes MA; Taupin JL; Neau-Cransac M
    Clin Transplant; 2014 Sep; 28(9):1054-60. PubMed ID: 25040585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of donor-specific HLA antibodies in transplantation, a review of the literature published in the last three years.
    Kaneku H
    Clin Transpl; 2010; ():283-306. PubMed ID: 21696047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving the performance of virtual crossmatch results by correlating with nationally-performed physical crossmatches: Obtaining additional value from proficiency testing activities.
    Wrenn SM; Marroquin CE; Hain DS; Harm SK; Pineda JA; Hammond PB; Shah DH; Hillyard SE; Fung MK
    Hum Immunol; 2018 Aug; 79(8):602-609. PubMed ID: 29864460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Donor-Specific Antibodies in Intestinal Transplantation: Experience at the University of California Los Angeles and Literature Review.
    Cheng EY; Kaneku H; Farmer DG
    Clin Transpl; 2014; ():153-9. PubMed ID: 26281140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The presence of donor-specific antibodies in renal transplantation.
    Tozkir H; Sağiroğlu T; Kiliçarslan-Ayna T; Tan S; Çopuroğlu E; Sağiroğlu G; Sari G; Gürkan H; Sezer A
    Transplant Proc; 2012; 44(6):1667-9. PubMed ID: 22841240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preformed complement-activating low-level donor-specific antibody predicts early antibody-mediated rejection in renal allografts.
    Lawrence C; Willicombe M; Brookes PA; Santos-Nunez E; Bajaj R; Cook T; Roufosse C; Taube D; Warrens AN
    Transplantation; 2013 Jan; 95(2):341-6. PubMed ID: 23197178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desensitization and heart transplantation of a patient with high levels of donor-reactive anti-human leukocyte antigen antibodies.
    Bućin D; Gustafsson R; Ekmehag B; Kornhall B; Algotsson L; Lund U; Otto G; Koul B
    Transplantation; 2010 Dec; 90(11):1220-5. PubMed ID: 20885338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation.
    Tait BD; Süsal C; Gebel HM; Nickerson PW; Zachary AA; Claas FH; Reed EF; Bray RA; Campbell P; Chapman JR; Coates PT; Colvin RB; Cozzi E; Doxiadis II; Fuggle SV; Gill J; Glotz D; Lachmann N; Mohanakumar T; Suciu-Foca N; Sumitran-Holgersson S; Tanabe K; Taylor CJ; Tyan DB; Webster A; Zeevi A; Opelz G
    Transplantation; 2013 Jan; 95(1):19-47. PubMed ID: 23238534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
    Caro-Oleas JL; González-Escribano MF; González-Roncero FM; Acevedo-Calado MJ; Cabello-Chaves V; Gentil-Govantes MÁ; Núñez-Roldán A
    Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and anti-HLA antibody profile of nine renal transplant recipients with failed grafts: donor-specific and non-donor-specific antibody development.
    Rebellato LM; Ozawa M; Verbanac KM; Catrou P; Haisch CE; Terasaki PI
    Clin Transpl; 2006; ():241-53. PubMed ID: 18365382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of Panel Reactive Antibodies in Renal Transplant Recipients Detected by Luminex: A Single-Center Experience.
    İnal A; Özçelik Ü; Ogan Uyanık E; Külah E; Demirağ A
    Exp Clin Transplant; 2016 Aug; 14(4):401-4. PubMed ID: 26517205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Pretransplant Donor-Specific Alloantibodies With Different Crossmatch Techniques.
    Moszkowska G; Zieliński M; Zielińska H; Dukat-Mazurek A; Dębska-Zielkowska J; Dębska-Ślizień A; Rutkowski B; Trzonkowski P
    Transplant Proc; 2018; 50(6):1625-1630. PubMed ID: 30056871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The acceptable reactive crossmatch (ARC), post-transplant monitoring, and their impact on kidney transplantation: a single center experience.
    Leone JP; Bowers V; Baliga R; Sanders C; LeFor W; Becker D; Thompson D; Resto-Ruiz S; Lopez-Cepero M
    Clin Transpl; 2011; ():373-9. PubMed ID: 22755434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.